Exane BNP Paribas analyst Nate Crossett upgraded Medical Properties Trust (MPW) to Outperform from Neutral with a price target of $9, up from $5. The stock is up sharply year-to-date on developments including new tenant payments following bankruptcy of tenant Steward, and the firm contends that shares can continue to re-rate higher as new tenant payments continue to ramp, the analyst tells investors in a research note. The firm believes that earnings of Medical Properties Trust should go higher over time.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MPW:
- Medical Properties Trust price target raised to $5 from $4 at RBC Capital
- Medical Properties Trust price target raised to $5 from $4 at Wells Fargo
- Fastly, Texas Instruments, Medical Properties, SolarEdge, Waste Management: Stock Moves Unveiled!
- Massachusetts Bill 5159: A Looming Threat to Medical Properties Trust’s Expansion Plans
- Medical Properties Trust’s Resilient Earnings Call Analysis